Assistant Professor, University of Washington Philosophy: In treating patients with cancer, I see the physician-patient relationship as a team. I work closely with patients to create an individual treatment plan, incorporating the best of recent advances. I see my role as that of teacher, coach, and advisor, to help patients make the best decisions about their cancer. I think it is important to discuss clinical trials whenever appropriate, as this is an important part of advancing cancer care.
Multiple myeloma, amyloidosis, Waldenström macroglobulinemia, monoclonal gammopathy, smoldering myeloma, plasmacytoma, POEMS syndrome, plasma cell leukemia and Castleman disease.
High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (LY3039478) to Treat Relapsed or Persistent Multiple Myeloma
years treating myeloma: 5
Number of Myeloma Patients Treated Annually: 150-200
Details & contact info
825 Eastlake Avenue East Eastlake Capitol Hill
Seattle, WA, United States, 98109
Send a message to Andrew J. Cowan, MD